These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 11890097
1. The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences. Chu DT, Zhang XR, Li JL, Qu FL, Sun Y. Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():117-24. PubMed ID: 11890097 [No Abstract] [Full Text] [Related]
7. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer. Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A, French Thoracic Oncology Collaborative Group (GCOT). J Natl Cancer Inst; 2005 Apr 06; 97(7):499-506. PubMed ID: 15812075 [Abstract] [Full Text] [Related]
8. Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study. Planchard D, Bourgeois H, Adoun M, Paitel JF, Blanc P, Genet D, Ferru A, Meurice JC, Deletage C, Tourani JM. Am J Clin Oncol; 2006 Aug 06; 29(4):345-51. PubMed ID: 16891860 [Abstract] [Full Text] [Related]
10. Adjuvant chemotherapy in resected non-small cell lung cancer. Cangiano R. Rays; 2004 Aug 06; 29(4):435-7. PubMed ID: 15852732 [Abstract] [Full Text] [Related]
11. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer]. Li DX, Chen XB. Ai Zheng; 2002 Apr 06; 21(4):412-5. PubMed ID: 12452023 [Abstract] [Full Text] [Related]